AD Scientific Index
 Open Nav
Login Login Pricing & Plans Pricing & Plans
Karthikeyan Murugesan

Karthikeyan Murugesan

Foundation Medicine Inc. - Cambridge / United States
Natural Sciences / Molecular Biology & Genetics
AD Scientific Index ID: 4464178
-
person_outline Karthikeyan Murugesan's MOST POPULAR ARTICLES
1-) PD-L1 expression and tumor mutational burden are independent biomarkers in most cancers JCI insight 4 (6), e126908, 2019
2-) Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer Journal for immunotherapy of cancer 9 (8), e002891, 2021
3-) Somatic HLA class I loss is a widespread mechanism of immune evasion which refines the use of tumor mutational burden as a biomarker of checkpoint inhibitor response Cancer Discovery 11 (2), 282-292, 2021
4-) Charting co-mutation patterns associated with actionable drivers in intrahepatic cholangiocarcinoma Journal of hepatology 78 (3), 614-626, 2023
5-) Profiling of 3,634 cholangiocarcinomas (CCA) to identify genomic alterations (GA), tumor mutational burden (TMB), and genomic loss of heterozygosity (gLOH). Journal of Clinical Oncology 37 (15_suppl), 4087-4087, 2019